Announced Tue, 7 Apr · 15:16 IST

Jupiter Life Line Hospitals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹1199.00
prior close
₹1199.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.7+0.5+1.7+2.8+4.9+4.1+5.4+7.0+3.4+4.3+11.6+21.9
Up moveDown movePending
AI summary

Jupiter Life Line Hospitals has filed its annual compliance disclosure under SEBI Takeover Regulations, confirming that none of its promoters, promoter group members, or persons acting in concert have created any encumbrance (such as pledge or lien) on the company's shares during the financial year ended March 31, 2026. The disclosure was signed by Dr. Ankit Thakker, Promoter and Joint Managing Director & CEO, on behalf of the entire promoter group. The total promoter and promoter group shareholding stands at 40.91%, i.e., 2,68,25,623 shares. The top individual holders are Ajay Thakker (20.74%), Ankit Thakker (6.67%), and Kirtika Thakker (2.03%), while Western Medical Solutions LLP holds 8.70%. This is a routine annual regulatory filing required under SEBI's takeover norms.

Likely market impact

This is a neutral, routine compliance filing with no material change in ownership or pledging. Shareholders can take comfort that promoters have not pledged any of their shares during the year, which removes concerns about potential margin calls or forced selling.